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It has been shown that mice thymectomized at 2 months of age have di- 
minished  numbers  of  lymphoeytes in  their  peripheral  blood  and  lymphoid 
tissues (1) but no defects in immune responses (2). When, however, thymectomy 
was followed by a potentially lethal dose of ionizing irradiation and bone mar- 
row therapy, the mice failed to respond, at 2 months postirradiation,  to skin 
homografts and  sheep  erythrocytes.  Sham-thymectomized control  mice,  on 
the other hand, had perfectly normal immune responses when tested 4 to  10 
weeks  after  irradiation  and  marrow  therapy.  It was  concluded that  the  re- 
covery of the immune mechanism after  total body irradiation  is  thymus-de- 
pendent (2). 
The present  experiments  were undertaken  to study the  effects of varying 
different parts of this system such as the number, source, and type of cells used 
for therapy and the age of the host at thymectomy. In addition, the growth of 
the  mice  and  their  immune  response  at  later  times  after  irradiation  were 
studied. 
Materials and Methods 
Aniraals.--Male mice of the CBA strain were used throughout as hosts and donors of bone 
marrow, spleen, and fetal liver cells. Male mice of the strains Ak, C3H, C57BL, and BALB/c 
were used as donors of skin. The strains C57BL and BALB/c differ from CBA at the strong 
histocompatibility locus H-2. The strains Ak, C3H, and CBA differ from one another at 
histocompatibility loci other than H-2 and thus have only  weak immunogenetic differences. 
All the mice used have been highly inbred at the Chester Beatty Research Institute. 
Thymectomy and Irradiagon.--Thymectomy was performed as described previously (3). 
Mice were irradiated in groups of 5 in a  perspex box, by means of a 220 kv Westinghouse 
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x-ray machine, half value layer 0.4 mm Cu, focal distance 100 cm, dose rate 60 roentgens/ 
minute. The dose of radiation used throughout was 850 r which is an LD~/30 days for Chester 
Beatty CBA mice. Bone marrow and spleen cells were taken from 8-week-old donors, counted, 
suspended in 0.4 ml of 199 culture medium, and injected 4 to 6 hours after irradiation. Foetal 
liver cells were taken from foetuses in the 3rd week of gestation. No effort was made to assess 
the exact age of the fetuses. A cell suspension was prepared by means  of a  ground  glass 
homogenizer, washed, and injected as above. 
Tests for Immuz~ Respomes.--Two  methods of testing  the immune response were used: 
(a) skin grafting according to the method of Billingham and Medawar, (4), and (b) the pro- 
duction of haemagglutinins after intraperitoneal  injection of sheep erythrocytes. 1 The CBA 
mice used had no naturally  occurring agglutinins to sheep erythrocytes. 
The basic experimental design used throughout  is shown in Table I. 
TABLE I 
Experimental Schalule 
~-ge, wks.. . 
Postirradiation, 
days, 
~ontrol  group  I 
~ontrol  group  II 
Experimental 
group I 
~-xperimental 
group II 
Sham thymec- 
tomy 
Thymectomy 
10 
850 r and therapy 
Sham  irradiation 
and therapy 
14 
28 
18 
60 
19 
67 
Thymectomy 
Thymectomy 
850 r  and therapy  Skin 
(cells from  nor- 
mal donors) 
850 r  and therapy 
(cells  from  ne- 
onatally thymec- 
tomlzed donors) 
Sheep  erythro- 
grafted  cytes  in- 
jected (first 
injection) 
Haemagglutinins  Haemag- 
tltrated  and 
sheep erythro- 
cytes  injected 
(second injec- 
tion) 
glutinins 
titrated 
RESULTS 
Long-Term Effects.--In previous experiments many thymectomized irradiated 
mice had lost weight, and about 25 per cent died between 30 and 80 days' post- 
irradiation.  In  order  to  study  changes  in  weight  and  mortality,  mice  were 
thymectomized  and  irradiated,  given  5  million  bone marrow  cells,  and  left 
without  further  treatment.  Controls  received  irradiation  and  bone  marrow 
only. The results are shown in Fig. 1. Mter an initial loss of weight during the 1st 
week postirradiation,  the mice in both groups gained weight at approximately 
the same rate during the next 2 weeks. Thereafter, only the mice in the control 
group continued to gain weight. The weights of the mice in the experimental 
group remained stationary from 30 to 70 days' postirradiation and began to rise 
only after  70 days.  In this  experiment,  although the  condition of the experi- 
mental mice was poor during the period up to 70 days, there was no mortality. 
1 Sheep  erythrocytes were  obtained  from  WeUcome  Research  Laboratories,  Beckenham, 
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The deaths recorded in previous studies may have been due to the fact that 
other manipulations such as skin grafting and bleeding had been performed. 
In view of the fact that both the appearance and weight of the experimental 
mice improved after 70 days, the immune responses of groups of mice similarly 
treated were tested at times later than 70 days' postirradiation. Mice which had 
first been skin grafted at 28 days' postirradiafion were regrafted at  128 days 
(Table II): 23 out of 24 mice still carried the Ak skin grafts and 17 out of 24 
carried the C57BL grafts. On regrafting, some of the controls showed a rather 
TABLE II 
Skin  Graft Survival Times in  CBA  Mice  Thymedomized and Irradiated at 2 Months of Age 
Treatment 
Control group I 
Sham-thymectomized  and 
irradiated; syngeneic 
bone marrow 
Eontrol group II 
Thymectomized  and 
sham-irradiated; syn- 
geneic bone marrow 
Experimental group I 
Thymectomized  and ir- 
radiated; syngeneic 
bone marrow 
No. 
of 
mice 
in 
! group 
18 
25 
24 
No. of 
mice  No. of 
with  mice 
Skin grafted  skin  grafted Skin grafted at 
at 30 days  sur-  again  100 days 
viving  at 100 
100  days 
days 
Ak  0  4  C3H 
C57BL  0  BALB/c 
C57BL 
Ak  0  24  C3H 
C57BL  0  BALB/c 
C57BL 
Ak  23  24  C3H 
C57BL  17  BALB/c 
C57BL 
No. of mice 
showing survival 
of second skin 
graft for: 
<20  20-  50  >50 
days  days  days 
2  2  0 
4  0  0 
4  0  0 
14  10  0 
24  0  0 
24  0  0 
5  4  15 
7  5  12 
7  9  8 
slow rejection of the C3H graft. However, only in the experimental group were 
grafts retained for periods longer than 50 days. Previous challenge with C57BL 
skin prejudiced, in some mice, the survival of a second C57BL graft to a slight 
extent, with only 8 of these remaining intact for longer than 50 days as  com- 
pared to 12 BALB/c grafts. Seven mice rejected the second C57BL graft while 
the first remained intact. 
Mice previously challenged with sheep erythrocytes at 60 and 67 days after 
irradiation, were again challenged at 150 days (Table III). Most of the mice in 
the  experimental group still produced no detectable titres  of antibodies but 
the mean titre was significantly higher than at 60 days' postirradiafion (P < 
0.01). A group of mice, which had not previously been challenged in any way, A.  M.  CROSS~  E.  LEUCHARS~  AND  J.  F.  A.  P.  MILLER 
TABLE Ill 
Immune Response o/ Thymectomized Irradiated CBA Mice to Sheep Erythrocytes 
841 
Treatment 
Control group I 
Sham-thymectomized and 
irradiated; syngeneic 
bone marrow 
Control group II 
Thymectomized and sham- 
irradiated;  syngeneic 
bone marrow 
Experimental group I 
Thymeetomized and ir- 
radiated; syngeneic bone 
marrow 
Experimental group I* 
Thymectomized and ir- 
radiated; syngeneic bone 
marrow 
f mice showing  following 
Laemmagglutinin titers: 
Mean log2 titer and 
standard deviation 
8.86  4-  0.2673 
11.67  ±  2.416 
8.75  4-  0.4085 
14.62  4-  3.162 
0.464  -4-  1.210 
2. 208  4-  2. 973 
3.83  q-  1.354 
* No previous challenge with antigen. 
TABLE  IV 
Response of CBA Mice, Thyme~tomized at 5 Montl~ of Age, to Allogendc Skin Grafts 
Treatment 
Thymectomized, irradiated;  syn- 
geneic bone marrow 
Thymectomized, not irradiated 
No. c 
.m!  mice  Donor skin  ~up 
C3H 
C57BL 
C3H 
C57BL 
No. of mice showing  skin graft 
survival for: 
<20 days 
0 
0 
6 
6 
20-50 days 
0 
1 
0 
0 
~,50 days 
was given sheep red cells at 150 days. The mean fitre in this group was rather 
higher than that in the previous group but the differences were not significant. 
Effect of Thymectomy in Older Mice.--In  a small group of mice, thymectomy 
was performed at 5 months instead of 8 weeks of age (Table IV). These mice 842  RECOVERY  OF IMMUNE  RESPONSE 
TABLE  V 
Effect of Various Doses of Bone Marrow Cells on the Response of Thymeaomized Irradiated 
CBA Mice to Allogeneic Shin Grafts 
No. of marrow cells 
injected 
1  X  10 n 
5 X  106 
10 X  10  s 
20 X  10  s 
40 X  106 
No. of mice 
in group 
8 
11 
Donor skin 
Ak 
C57BL 
Ak 
C57BL 
Ak 
C57BL 
Ak 
C57BL 
Ak 
C57BL 
No.  of mice  showing  skin  graft survival  for: 
<20 days  20-70 days 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  I 
0  3 
0  0 
0  6 
>70 days 
TABLE VI 
Effect of Various Doses of Bone Marrow Cells on the Response of Thymeaomized Irradiated CBA 
Mice to Sheep Erythrocytes 
No. of marrow  Antigen 
cells injected  challenge 
1 X  106  First 
Second 
5 X  10  s  First 
Second 
10 X  10  s  First 
Second 
20 X  10  s  First 
Second 
40 X  10  e  First 
Second 
No. of 
mice in 
group 
13 
13 
1 
1 
1 
3 
!2 
No. of mice showing  following  log2 
haemagglutinin  titer: 
2  3  4  5  6  7181 
1 
1 
1 
1 
15  1 
3  1  1  2 
Mean logs titer and 
standard deviation 
9 
0.75  -4-  1.30 
2.05  4-  1.58 
!  0.16674-  0.37 
1.16674-  1.47 
0.66674-  1.47 
1.16674.  1.47 
0.25  4.  0.43 
1.05  4-  1.22 
2.2314-  1.46 
3.2314-  2.63 
showed  the  same  inability  to  reject  allogeneic  skin  grafts  as  those  thymec- 
tomized at an earlier age. 
Variation  of Cell Number.--In  the  experiments described  above,  the  mice 
were given a  dose of 5  million  bone  marrow  cells after  irradiation.  The effect A.  M.  CROSS, E.  LEUCHARS~ AND J.  F.  A.  P.  MILLER  843 
d  varying this dose from 1 to 40 million cells was studied. The injection of as 
many as 40 million ceils failed to restore more than a  weak immune response 
and in many mice there was no effect.  Only a  few mice gave evidence of any 
ability to reject skin homografts (Table V). A  similar picture was seen when 
the mice were challenged with sheep erythrocytes (Table VI). In this case, the 
titres were not increased except in mice given 40 million cells,  and even this 
increase  was  not  statistically  significant. 
TABLE VII 
Effect of Pretreatment of Bone Marrow Donor on Recovery of Immune Response in Syngeneic 
Radiation Chimeras 
Marrow  donor 
Age  Pretreatment 
~05. 
2  Nil 
Neonatal thymectomy 
Sham thymectomy, 850 r, syn- 
geneic bone marrow 
Thymectomized, sham-ir- 
radiated, syngeneic  bone 
marrow 
Thymectomized, 850 r, syn- 
geneic bone marrow 
No. of 
irradiated 
recipients 
18 
I0 
ii 
ii 
Donor  skin 
Ak 
C57BL 
Ak 
C57BL 
Ak 
C57BL 
Ak 
C57BL 
Ak 
C57BL 
No. of mice showing skin graft 
survival for: 
<20 days 
18 
18 
6 
10 
20-50  days >50 days 
0  0 
0  0 
4  0 
0  0 
8  0 
7  0 
11  0 
ii  0 
ii  0 
i0  0 
Use of Marrow from Thymectomized Mice.--An experiment was performed to 
determine whether bone marrow cells from mice, which were themselves unable 
to reject skin grafts or produce sheep haemagglutinins, could restore immuno- 
logical capacity in irradiated  non-thymectomized mice (Table VII). Animals 
which had received bone marrow cells  from 2-month-old neonatally thymec- 
tomized mice showed almost normal immune responses.  Only in a  few cases 
was there a  slight prolongation of the survival time of allogeneic grafts from 
donors with the same H-2 locus as the host. All mice given bone marrow cells 
from 9-month-old donors rejected skin grafts more slowly than normally, but 
experimental mice, given marrow from thymectomized irradiated donors, gave 
the same rejection times as the controls. 
Variation of Cell Type.--It is dear, from the above results, that bone marrow 
cells  will  not restore  immunological capacity in  the  absence of the  thymus. 844  RECOVERY  OF IMMUNE  RESPONSE 
It was, therefore,  decided  to see whether a  different type of tissue would be 
effective. 
Mice were given 10 million spleen cells after irradiation and the experimental 
schedule from Table I  was used.  The skin grafting results are given in Table 
VIII. It can be seen that,  although  the mice in the first experimental group 
showed rather long rejection times, there were no mice which showed survival 
of grafts for longer than 40 days. Similarly, the haemagglutinin titres of mice 
TABLE VIII 
Effect  of Syngeneic  Spleen  Cdls on the Response  of Thymectomized  Irradiated  CBA  Mice to 
Allogendc  Skin Grafts 
Treatment 
Control group I 
Sham thymectomized and irradiated; 
syngeneic spleen cells 
Control group II 
Thymectomized, and sham-irradi- 
ated; syngeneic spleen cells 
Experimental group I 
Thymectomized and irradiated; syn- 
geneic spleen cells from normal 
donors 
Experimental group II 
Thymectomized and irradiated; syn- 
geneic spleen cells from neonatally 
thymectomized donors 
No. of 
mice in 
group 
16 
16 
28 
28 
40 
40 
Donor skin 
Ak 
C57BL 
Ak 
C57BL 
Ak 
C57BL 
Ak 
C57BL 
No. of mice showing skin graft 
survival for: 
<20  20-4~  40-7  >70 
days  day,,  day  days 
3  0  0 
0  0  0 
0  0  0 
0  0  0 
28  0  0 
10  0  0 
1  1  4 
1  0  7 
in the first experimental group (Table IX) were significantly lower than those of 
control mice (first challenge, P  <  0.01; second challenge P  <  0.05), but were 
much higher than those seen in mice given bone marrow. A different picture is 
seen  when  spleen  cells  were  taken  from  neonatally  thymectomiz~d  donors 
(experimental group II). In most of these animals,  skin grafts were retained 
for long periods (Table VIII) and haemagglutinins were produced in low titres 
or were not detectable (Table IX). 
In a  subsequent experiment, mice were given 5 million foetal liver cells after 
irradiation. They reacted in a  similar way to those given bone marrow, being 
unable to reject allogeneic skin grafts (Table X) and to produce normal titres of 
sheep haemagglutinins (Table XI). A.  M.  CROSS~ E.  LEUCHARS~  AND  J.  F.  A.  P.  MILLER  845 
TABLE  IX 
Effect of Syngeneic Spleen  Ceils on the Response of Thymectomized Irradiated  CBA  Mice to 
Sheep Erytkrocytes 
Antigen 
Treatment  challenge 
Control group I 
Sham-thymectomized and  First 
irradiated; syngeneic  Second 
geneic spleen cells 
Control group II 
Thymectomized and sham-  First 
irradiated; syngeneic  Second 
spleen cells 
Experimental group I 
Thymectomized and ir-  First 
radiated; syngeneic  Second 
spleen cells from normal 
donors 
Experimental group II 
Thymectomized and ir-  First 
radiated; syngeneic  Second 
spleen cells from neo- 
natally thymectomized 
donors 
No.  No. of mice showing following 
of  log4  haemagglutinin fiters: 
mice 
in 
group  0  1  2  3  4  5  6  7  8  9 
11  3  8 
15  9  6 
15  14  1 
14  13  1 
30  22  8  !  1  25  121  3 
9  (  3 
9  4221  i 
! 
1 
Mean log2 titer and 
standard deviation 
7.45  4-  0.9045 
8.80  4-  0.9660 
8.133  4-  0.5164 
10.140  4-  0.5436 
6.533  4-  0.8944 
8.160  4-  0.7746 
1.330  4-  1.300 
2.500  4-  1.699 
TABLE  X 
Effect of Syngeneic Foetal Liver Cells on the Response of Tkymectomized Irradiated CBA Mice 
to AUogenei¢ Skin Grafts 
Treatment 
Control group I 
Sham-thymectomized and irradiated; 
syngeneic foetal  liver  cells 
Control group II 
Thymectomized and sham-irradiated; 
syngeneic foetal liver cells 
Experimental group I 
Thymectomized and irradiated;  syn- 
geneic  foetal  liver  cells 
No.  of 
mice  in 
group 
18 
19 
21 
23 
21 
21 
Donor skin 
C3H 
C57BL 
C3H 
C57BL 
C3H 
C57BL 
No. of mice showing skin graft 
survival for: 
<20 days  l 
11 
15 
18  3 
22  1 
20-70  days  > 70 days 
0 
0 
18 
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DISCUSSION 
The results presented here confirm and extend previous observations (2, 5) 
indicating that there is a  failure of the recovery of the immune apparatus in 
adult mice thymectomized and irradiated. Recovery of immunological function 
in the irradiated CBA mice, used in the present experiments, could take place 
only if either the  thymus was present or if spleen cells from normal mice were 
provided. Adult marrow and foetal liver cells did not promote such a recovery 
in the absence of the thymus. 
TABLE  XI 
Effect  of Syngeneic  Foetal LiverCells on the Response of Thymectomized Irradiated  CBA Mice 
to Sheep Erythrocytes 
Treatment 
Zontrol group I 
Sham-thymectomized and 
irradiated; syngeneic 
foetal liver cells 
Zontrol group II 
Thymectomized and sham- 
irradiated; syngeneic 
foetal liver cells 
Experimental group I 
Thymectomized and ir- 
radiated;  syngeneic foe- 
tal liver cells 
Antigen 
challenge 
First 
Second 
First 
Second 
First 
Second 
No. 
of 
mice 
in 
group 
No. of mice showing following 
log, haemagglutinin titers: 
0  1 
16 
14  i 
15 
15 
15  591 
13  fi  5  3 
2  3  4  5  6  7  8  9 
9  7 
185 
591 
1  4  ~  2 
Mean log~ titer and 
standard deviation 
9.625  +  0.7906 
10.93  ±  0.9636 
7.867  ±  0.9661 
11.93  +  1.4600 
1.667  q-  1.1830 
2.154  ~  1.710C 
Strong  evidence has  recently been  obtained  to  indicate  that  primary im- 
mune responses, in general, may be initiated  by small lymphocytes (6).  De- 
pletion of small lymphocytes by prolonged lymph drainage from the thoracic 
duct  suppresses  primary  antibody  responses  to  tetanus  toxoid  and  sheep 
erythrocytes  (7).  Neonatal  thymectomy, which  eventually  leads  to  marked 
lymphoid  atrophy  (8),  is  associated  with  an  inability  to  produce  primary 
immune  responses  to  standard  antigens  and  to  skin  homografts  (9).  The 
failure  of  thymectomized  irradiated  mice  to  recover  normal  levels  of  small 
lymphocytes (2) may thus explain their immunological inadequacies.  The un- 
responsive state in lymphocyte-depleted  animals can  be corrected  by an  in- 
jection of small lymphocytes or of lymph node and spleen cells from normal 
animals of the same inbred strain (7, 10). Likewise, in the present experiments, A.  M.  CROSS,  E.  LEUCHARS,  AND  J'.  :F.  A.  P.  MILLER  847 
injection of spleen cells from normal, but not from neonatally thymectom~zed 
animals, restored {mmnnologieal capacity. These results  indicate (a)  that im- 
munologically competent ceils are present in the drculation, spleen, and lymph 
nodes of normal animals and can function in the absence of the thymus, and 
(b) that only the development of an adequate population of such cells is thymus- 
dependent. 
Large numbers of ceils from bone marrow of adult donors failed to restore im- 
munological  capacity in  thymectomized irradiated mice.  Bone  marrow sus- 
pensions contain about 20 per cent of cells classifiable morphologically as small 
lymphocytes. It is thus apparent that there is not in marrow an adequate popu- 
lation of immunologically  competent cells, and that the majority of marrow 
small  lymphocytes must be functionally different from the majority of the 
small lymphocytes circulating  in blood and lymph and present in spleen and 
lymph nodes of normal adult animals. The marrow small lymphocytes  may thus 
belong to a population of cells that has, in its present state, no immunological 
function  whatsoever.  Whether  tMs  population  ever  gives  rise  to  im- 
munologically competent cells cannot be decided on the basis of present evi- 
dence. 
It has been clearly established  that after doses of irradiation such as those 
used in the present experiments, both the haematopoietic and lymphoid tissues 
of the host are repopulated by donor cells (II, 12). There must thus exist, in the 
marrow, a lymphoid precursor  cell the descendants of which can become hn- 
munologically competent in the presence  of thymus tissue.  Such a precursor 
cell must also exist in neonatally thymectomized mice since marrow from such 
animals effectively restored immune competence in irradiated mice. Neonatal 
thymectomy  is not, therefore, associated with the absence of lymphoid precur- 
sor cells or ceils capable of acquiring competence. The identity of such cells in 
marrow tissue is not established.  There is no evidence at the present time that 
the marrow small lymphocytes  may be such cells. 
Recent experiments  indicate that  the  immunological  inadequacies  of  the 
thymectomized irradiated mouse protected with marrow can be corrected  by 
grafting syngeneic or allogeneic thymus tissue. Furthermore, it can be shown 
that in this system, the immunologically competent cells have been derived from 
cells of the marrow donor. The mechanism by which the thymus enables such 
cells to become immunologically competent has to be determined. The thymus 
could conceivably  exert an influence through lymphoid precursor  ceils which 
migrate into the thymus first to reconstitute it and then recolonize the depleted 
lymphoid tissues. Alternatively, it could, by means of a humoral factor, induce 
the maturation of such cells in lymphoid tissues. Evidence has been given to 
show that a humoral thymus mechanism is involved in the maturation of im- 
munological faculties in the neonatal mouse  (13, 14). It now seems probable 
that a similar mechanism is also operative in the adult irradiated mouse (15). 848  RECOVERY  OF  IMMUNE  RESPONSE 
Animals  with depleted lymphoid tissues  in general  develop marasmus.  This 
is seen in infant mice following the neonatal injection of allogeneic  lymphoid 
cells (16), in lethally irradiated animals  injected with allogeneic bone marrow 
(17) or with low numbers of syngeneic marrow or foetal liver cells (18), in mice 
thymectomized at birth (9, 19), and in human infants with essential lymphocy- 
tophthisis (20), a disease characterized by thymus atrophy. Since all these con- 
ditions have both lymphoid atrophy and trophic disturbances, it has been sug- 
gested that the lymphocyte may be a "feeder" cell or trephocyte (21, 22). The 
thymectomized irradiated mice in the present experiments exhibited some de- 
gree of trophic disturbances during  the period 30 to 70 days postirradiation. 
Thereafter, however, their appearance improved and they began to increase in 
weight.  It may be argued that the trophic disturbances observed between 30 
and 70 days were dependent on lymphoid dysplasia. On this theory, however, 
it is difficult to explain the resumption of the increase of body weight which took 
place after 70 days at a time when the mice showed neither a significant increase 
in their peripheral blood mononuclear leucocyte counts (2) nor any apparent 
improvement in their immunological  capabilities. 
SUMMARY 
Experiments performed on CBA mice thymectomized in  adult life,  exposed to 
lethal  doses  of  irradiation  and  given tissue  therapy are described.  Marrow, foetal 
liver,  or spleen cells  from syngcneic donors could protect the mice against the 
lethal  effects  of irradiation.  Between 30 and 70 days'  postirradiation,  however, 
marrow-treated,  thymectomized  irradiated mice showed evidence of trophic 
disturbances, such as failure  to gain weight, in contrast to sham-operated,  ir- 
radiated,  marrow-treated controls.  The immune responses of experimental and 
control mice were tested up to 150 days' postirradiation  by challenging with 
sheep crythrocytcs and allogencic  skin grafts.  Sham-operated irradiated con- 
trols,  whether protected with marrow, foetal  liver,  or  spleen  cells,  produced nor- 
mal immune responses when challenged at 28, 60, or 150 days after  irradiation. 
Neither foetal  liver  cells  nor marrow cells,  in doses of up to 40 million cells  per 
mouse, enabled thymectomizcd irradiated  mice to  recover  normal immune func- 
tions,  Spleen cells,  from normal donors but not from neonatally thymcctomized 
donors, restored  immunological capacity in such mice. It is  concluded that im- 
munologically competent cells  are present in the spleen of normal adult donors 
and can function  in  the absence of  the thymus. Bone marrow, on the other hand, 
does not contain an adequate population of such cells  but has lymphoid precur- 
sor cells,  the descendants of which can become immunologically competent only 
in  the  presence of  a functioning  thymus mechanism. 
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